KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $4,926,000 | -3.0% | 493,584 | +23.7% | 0.01% | 0.0% |
| Q1 2015 | $5,078,000 | +27.8% | 398,911 | +42.1% | 0.01% | +20.0% |
| Q4 2014 | $3,973,000 | +9.9% | 280,804 | +6.8% | 0.01% | +11.1% |
| Q3 2014 | $3,616,000 | -2.2% | 262,966 | +9.4% | 0.01% | 0.0% |
| Q2 2014 | $3,697,000 | -26.9% | 240,361 | -19.0% | 0.01% | -35.7% |
| Q1 2014 | $5,058,000 | +79.9% | 296,817 | +36.8% | 0.01% | +55.6% |
| Q4 2013 | $2,811,000 | -2.3% | 217,031 | -23.8% | 0.01% | -10.0% |
| Q3 2013 | $2,878,000 | +59.9% | 284,901 | +18.2% | 0.01% | +25.0% |
| Q2 2013 | $1,800,000 | – | 241,013 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 700,273 | $10,770,000 | 5.76% |
| HARVEY CAPITAL MANAGEMENT INC | 932,400 | $14,340,000 | 5.13% |
| Camber Capital Management LP | 3,000,000 | $46,140,000 | 3.02% |
| Baupost Group | 10,539,986 | $162,105,000 | 2.64% |
| SECTORAL ASSET MANAGEMENT INC | 3,741,656 | $57,547,000 | 2.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,884,409 | $59,742,000 | 2.40% |
| Knoll Capital Management, LLC | 200,000 | $3,076,000 | 1.37% |
| DAFNA Capital Management LLC | 92,400 | $1,421,000 | 1.35% |
| NORTHPOINTE CAPITAL LLC | 892,011 | $13,719,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 240,000 | $3,691,000 | 1.10% |